| Developers: | Spark Biomedical |
| Date of the premiere of the system: | August, 2020 |
| Branches: | Pharmaceutics, medicine, health care |
2020: The announcement of a neurostimulator which allows newborns to wean from drugs which were done by the pregnant woman quickly
In the middle of August, 2020 the Spark Biomedical company provided Roo neurostimulator allowing newborns to wean quickly from drugs which were done by the pregnant woman. The applied therapy called by chreskozhny aurikulyarny neurostimulation (tAN) induces a brain to release endorphins which contact opioid receptors and by that reduce the need of a brain for opioids.
The children born from mothers with drug addiction from opioids suffer from a canceling syndrome in the first several weeks of life. For relief of symptoms during this period in intensive care units of newborns morphine is usually used. Traditionally disaccustoming borrows from two to four weeks, and all this time children are in intensive care unit. The neurostimulator of Roo allows to reduce disaccustoming time to ten days due to stimulation of branches of cranial nerves on an ear and about it. This technology was already successfully tested in clinical trials on the adult patients suffering from opioid abstinency, and now, in the sparing form, is appointed also the newborn.
 | Neurostimulation induces a brain to produce own endogenous opioids to reduce the need for exogenous morphine. Thus we reduce the probability of development of the dangerous ghost effects of this medicine arising at prolonged use that is especially important in such critical time of development of nervous system, - the associate professor of the Medical University of South Carolina (MUSC) doctor Bashar Badran notes. |  |
Bashar and group of the doctors specializing in treatment of newborns with opioid dependence in MUSC tested Roo neurostimulator on three children born with symptoms of canceling of opioids. The research included assessment of children on Finnegan's scale for control of symptomatology, purpose of therapy of tAN and carrying out one more assessment according to Finnegan. Three the tested children were separated from morphine on average in ten days.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |